Janux provided a program update on its Phase 1 study of JANX008, an EGFR-targeted TRACTr, following Phase 1a completion and ...

Coherus Oncology, Inc. is rated a Buy driven by a promising clinical pipeline and undervaluation. Learn more about CHRS stock ...

Sense of smell in patients with head and neck cancer began to deteriorate at a radiation dose of 22 Gy and increased in a ...

Pyxis Oncology released preliminary data from Phase 1 studies of MICVO for recurrent/metastatic head and neck squamous cell carcinoma.

David Caprio, known as the son of a warm and empathetic American judge, Frank Caprio, recently shared on Facebook that what ...

Squamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth ...

The monotherapy trial suggested a confirmed overall-response rate of 46% and a disease-control rate of 93%. In combination with Keytruda, the confirmed overall-response rate was 71% and the ...

Germany: A new retrospective study published in the European Journal of Radiology reports that using a 15-channel dental coil ...

ORR and 100% DCR observed with MICVO in combination with KEYTRUDA® (pembrolizumab) in 1L/2L+ R/M HNSCC at 3.6 mg/kg and 4.4 mg/kg Updated data from ongoing Phase 1 monotherapy study in 2L+ R/M HNSCC ...

Coulier’s New Cancer Diagnosis After Lymphoma In a shocking twist nobody saw coming, “Full House” legend Dave Coulier revealed he’s been diagnosed with a new form of cancer just months after he ...

HPV is the most common viral sexually transmitted infection. Linda Ratjama In a country where preventable diseases still claim too many lives, a new silent threat is slowly emerging: Head and neck ...